FindTrial
Sign In

Role of Cardiac MRI in prediction of abnormal heart rhythms in heart disease

Extracellular volume and scar characteristics as predictors of adverse cardiovascular events in structural heart disease - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/08/056448
Enrollment
58
Registered
2023-08-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I420- Dilated cardiomyopathy

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Kasturba medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Established dilated cardiomyopathy: Symptoms, LVEF 90ml/m2 on echocardiography Presence of left ventricular hypertrophy ( >18mm) Suspected/known cases of infiltrative cardiac disorders Patients with history of myocardial infarction

Exclusion criteria

Exclusion criteria: Patients with cardiac tumours Contraindications to CMR: Implantable devices, metallic cardiac valves, renal disease with reduced GFR etc Patients not on Holter monitoring/ ICDs Cases where all necessary sequences are not acquired due to patient factors

Design outcomes

Primary

MeasureTime frame
Cardiac T1 relaxation times (septal & global) on pre & post contrast maps ECV (extracellular volume) values on post contrast maps Timepoint: Cardiac T1 relaxation times (septal & global) on pre & post contrast maps ECV (extracellular volume) values on post contrast maps—

Secondary

MeasureTime frame
Morbidity & adverse outcomes in 6 to 8 month follow up periodTimepoint: 31 july 2025—

Countries

India

Contacts

Public ContactPrakashini K

kasturba medical college manipal

prakashini.k@manipal.edu9845053325

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026